Retatrutide
Supports weight loss, helps preserve lean muscle, reduces food cravings, aids metabolic health, lowers blood pressure, improves blood sugar control.
Research Benefits
Available at
Pantheon Peptides
Affiliate disclosure: PeptidesMaxxing earns a commission at no cost to you.
What is Retatrutide?
Retatrutide is a next-generation triple agonist peptide targeting three G-protein-coupled receptors simultaneously: GLP-1R (glucagon-like peptide-1 receptor), GIPR (glucose-dependent insulinotropic polypeptide receptor), and GCGR (glucagon receptor). This triple receptor engagement distinguishes Retatrutide from dual agonists like Tirzepatide and positions it as one of the most potent metabolic peptides currently in clinical development.
Mechanism of Action
GLP-1 Receptor Agonism
GLP-1 receptor activation reduces appetite, slows gastric emptying, enhances insulin secretion, and reduces glucagon secretion. This is the mechanism shared with semaglutide and other established weight loss compounds.
GIP Receptor Agonism
GIP receptor activation enhances the metabolic effects of GLP-1, improves insulin sensitivity, and may help preserve lean muscle mass during caloric deficit. The GIP axis also has effects on adipose tissue metabolism independent of caloric intake.
Glucagon Receptor Agonism
Glucagon receptor activation increases energy expenditure, promotes lipolysis (fat breakdown), and enhances hepatic fat metabolism. This additional receptor engagement is what separates Retatrutide from dual agonists — glucagon signaling adds a direct energy expenditure component that augments caloric deficit.
Key Research Findings
Phase 2 Clinical Trial Results
Retatrutide's Phase 2 clinical trial (published in the New England Journal of Medicine, 2023) demonstrated weight loss averaging 17.5% at 24 weeks with the highest dose studied — substantially exceeding results seen with semaglutide or Tirzepatide at comparable timepoints.
Muscle Preservation
Despite aggressive caloric deficit, Retatrutide-treated subjects showed preservation of lean body mass — a critical advantage over purely caloric restriction approaches where significant muscle is lost alongside fat.
Lipid and Metabolic Markers
Significant improvements in triglycerides, LDL cholesterol, blood pressure, and insulin sensitivity were documented alongside the weight loss effects — suggesting comprehensive metabolic benefit beyond fat mass reduction.
*For research use only. Not for human consumption.*
Research Use Only: This product is for laboratory research purposes only. Not intended for human consumption. Not approved by the FDA for any therapeutic use. Consult a qualified physician before any use.
Ready to order Retatrutide?
Research-grade purity from Pantheon Peptides.
Related Research
You Might Also Need
Reduces abdominal fat, enhances metabolic function, supports muscle maintenance, improves skin elasticity, enhance mental clarity.
Weight management, Diabetes control, Cardiovascular health, Improves insulin sensitivity, Supports metabolic health.
Supports sustainable weight loss, reduces appetite and food cravings, enhances metabolic efficiency, preserves muscle mass during fat loss.